Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial
Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.

Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a Phase 1 study of ADXS-NEO and the addition of a new revision number and a focus on personalized immunotherapy treatment design.SummaryDifference60%
Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.